The Big Lung Trial: Does Short-Term Chemotherapy Improve the Survival of Patients with Non-Small Cell Lung Cancer (NSCLC)

Not Applicable

Completed

• Conditions: ung (non-small cell); Cancer; Lung (non-small cell)

• Registration Number: ISRCTN57155593
• Lead Sponsor: HS R&D 'Time-Limited' National Programmes

Brief Summary

1. 2004 results in http://www.ncbi.nlm.nih.gov/pubmed/15200998 2. 2005 results in http://www.ncbi.nlm.nih.gov/pubmed/16094738 3. 2005 results in http://www.ncbi.nlm.nih.gov/pubmed/16157935

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2002-08-19
• Study Completion: 2005-12-31
• Last Update Posted: 19 November 2018

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. Fulfil local criteria for diagnosis of NSCLC
2. Be fit to receive, and have no clear contraindications to chemotherapy
3. Patients randomised to adjuvant chemotherapy should be able to start chemotherapy within 10 weeks of completion of surgery or radical radiotherapy
4. No concurrent malignancy, or any history of malignancy, other than non-melanomatous skin cancer within the last 3 years

Exclusion Criteria

Not provided at time of registration

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ot provided at time of registration

Secondary Outcome Measures

Name	Time	Method
ot provided at time of registration